Locations:
SearchAdvertisement
Guidance for evaluating and monitoring patients based on results from several studies
Two-drug therapy reduces progression in rare hereditary cancer syndrome
Which cysts turn malignant and why NSAIDs can be chemoprotective
Too few patients assessed before undergoing biologic dose changes
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Research suggests T2D variants with differing metabolic responses to gastric bypass
Cleveland Clinic study finds increased detection may not mean higher risk of metachronous advanced neoplasia
Method can eliminate need for liver biopsies in significant number of patients
Study finds a 43% lower risk of HCC in statin users
Cleveland Clinic study finds that both gastroenterologists and colorectal surgeons meet quality benchmarks
A quick review of several advances in risk assessment and treatment
Advertisement
Advertisement